Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Germany paid the most for benzoic acid excipient in Q2 2026: USD 1,869/MT, up 1.7% from USD 1,838 in Q1. The steady pharmaceutical-excipient demand kept things firm there. Worldwide, the average moved up 1.6%, to USD 1,621/MT from USD 1,595, largely because the toluene feedstock costs kept climbing across every region we track. What about H2 2026? We'd expect a global average somewhere in the USD 1,595-1,730/MT range, with the steady pharmaceutical and food-preservative demand doing most of the work.
Benzoic acid excipient is made by oxidizing toluene, then purified to the pharmaceutical, USP-NF grade that formulators need for tablet and syrup preservative systems, distinct from the technical grade that goes into industrial and food applications. It works as an antimicrobial preservative in oral liquid formulations and as a processing aid in some solid-dose manufacturing. A food-grade variant, listed as E210, serves the same preservative function in packaged foods and beverages. Three things move the price more than anything else: the toluene feedstock costs, the pharmaceutical-formulation demand tied to generic-drug manufacturing, and how much purification capacity the producers are running to meet the USP-NF specifications.
The distinction between the pharmaceutical and technical grades matters more than it might first appear, since the two effectively operate as separate markets even though they share the same underlying chemistry. Reaching USP-NF purity requires additional purification steps beyond what the technical or food grades need, and those steps add real cost. That's why pharmaceutical-grade benzoic acid trades at a premium even though the base molecule is identical across all three grades, and why disruptions to a producer's purification capacity specifically, rather than its basic production capacity, can tighten pharmaceutical-grade supply even when the broader benzoic acid market looks well supplied.
The toluene link is worth flagging too, since it ties this market to the broader petrochemical complex in ways that aren't always obvious. Toluene itself is a byproduct of petroleum refining and naphtha cracking, which means its price can move for reasons entirely unrelated to pharmaceutical demand, whether that's a refinery outage, a shift in gasoline-blending economics, or broader crude oil price swings. Buyers should also note that toluene itself sees periodic supply tightness during peak gasoline-blending seasons in some regions, a dynamic that occasionally shows up as unexpected cost pressure in this market despite having nothing to do with pharmaceutical demand.
Supply and demand should stay moderately tight through H2 2026, with the toluene feedstock costs doing most of the work on pricing. Germany and the US both kept the pharmaceutical-excipient demand steady through H1, and that's likely to continue. India's formulation sector kept the import demand building, while China's large production base kept it the most affordable of the four.
Buyers of the pharmaceutical-grade material specifically should watch purification capacity utilization as closely as the underlying toluene market, since the two don't always move together and a bottleneck in purification alone can tighten pharmaceutical-grade availability even when technical-grade supply looks ample.
Buyers should also keep in mind that switching between technical and pharmaceutical grades is not a simple substitution, since formulators generally cannot use technical-grade material in a regulated pharmaceutical product regardless of price differences between the two. Regulatory filings for pharmaceutical products typically specify an approved supplier list, and adding a new source, even one making chemically identical material, usually requires a formal qualification process. That structural friction is part of why pharmaceutical-grade pricing can stay elevated relative to the technical grade even when the underlying toluene market eases.
What could push prices higher? A toluene feedstock spike, or a stronger-than-expected pharmaceutical-formulation demand surge. What could pull them lower? A slowdown in generic-drug manufacturing activity.
| Region | 2026 Price Range (USD/MT) | Outlook |
| Global Average | 1,595 - 1,730 | Steady pharmaceutical demand and firm feedstock costs support |
| China | 1,425 - 1,545 | Large production base keeps China most affordable |
| United States | 1,770 - 1,920 | Steady formulation demand |
| Germany | 1,845 - 2,000 | Established pharmaceutical-excipient demand commands premium |
| India | 1,560 - 1,690 | Growing generic-formulation demand |
China's benzoic acid excipient producers passed through the firmer toluene costs this quarter, and the domestic pharmaceutical demand held steady. The gain came to 1.7%, USD 1,419/MT to USD 1,443.
Why did the price of Benzoic Acid Excipient change in Q2 2026 in China?
The toluene feedstock costs firmed through the quarter, and the domestic pharmaceutical demand held its ground right alongside that.
USD 1,794/MT. That's where the US landed in Q2, up 1.7% from USD 1,764 in Q1. The formulation demand stayed steady, and the toluene costs climbed just enough to push things higher.
Why did the price of Benzoic Acid Excipient change in Q2 2026 in United States?
The formulation demand didn't move much, honestly. It was the toluene feedstock costs doing most of the work this quarter.
Germany gained 1.7% to USD 1,869/MT, the established pharmaceutical-excipient demand staying firm through the period.
Why did the price of Benzoic Acid Excipient change in Q2 2026 in Germany?
Germany's premium held for the usual reason: steady pharmaceutical-excipient demand backed by firming toluene costs.
India climbed 1.7% to USD 1,580/MT, the generic-formulation demand continuing to build through the period.
Why did the price of Benzoic Acid Excipient change in Q2 2026 in India?
The generic-formulation demand kept building, and that alone explains most of the move here.
China gained 1.6% to USD 1,419/MT, the demand firming as the year opened.
Why did the price of Benzoic Acid Excipient change in Q1 2026 in China?
The domestic pharmaceutical demand firmed as the year opened, and the toluene feedstock costs edged higher right alongside it.
US benzoic acid excipient rose 1.7% to USD 1,764/MT, the formulation demand firming with the new year.
Why did the price of Benzoic Acid Excipient change in Q1 2026 in United States?
The formulation demand firmed with the new year, and the toluene costs kept climbing steadily too.
Germany gained 1.7% to USD 1,838/MT, the pharmaceutical-excipient demand staying firm through the quarter.
Why did the price of Benzoic Acid Excipient change in Q1 2026 in Germany?
The pharmaceutical-excipient demand stayed firm, and the toluene costs firmed alongside it.
India climbed 1.6% to USD 1,554/MT, the generic-formulation demand building through the quarter.
Why did the price of Benzoic Acid Excipient change in Q1 2026 in India?
The generic-formulation demand built through the quarter, tracking the pharmaceutical manufacturing activity closely.
The global average climbed steadily across the window, from USD 1,520/MT in Q1 2025 to USD 1,621 by Q2 2026, a net gain of about 6.6%. Every quarter posted a gain here, reflecting the firming toluene feedstock costs and the steady pharmaceutical-excipient demand across every market we track, with the pace staying fairly consistent throughout the window.
| Quarter | Price (USD/MT) | QoQ Change | Direction |
| Q2 2026 | 1,621 | +1.6% | ↑ Rising |
| Q1 2026 | 1,595 | +1.7% | ↑ Rising |
| Q4 2025 | 1,569 | +1.1% | ↑ Rising |
| Q3 2025 | 1,552 | +1.1% | ↑ Rising |
| Q2 2025 | 1,535 | +1.0% | ↑ Rising |
| Q1 2025 | 1,520 | - | - Stable |
| Q3 2026 | In Progress | - | - In Progress |
2025 was a steadily firming year for benzoic acid excipient. Starting near USD 1,520/MT in Q1, the global average finished 2025 at USD 1,569, a gain of about 3.2%. The toluene feedstock costs firmed gradually all year, and the pharmaceutical-excipient demand held dependable throughout, giving the year a fairly orderly, predictable shape.
Chinese prices moved from about USD 1,350/MT in Q1 2025 to USD 1,396 by Q4, up roughly 3.4%. The domestic demand held steady all year, and China stayed the most affordable of the four markets throughout.
US prices climbed from USD 1,680/MT in Q1 to USD 1,735 by Q4, a 3.3% gain, tracking the steady formulation demand.
German prices rose from USD 1,750/MT in Q1 to USD 1,808 by Q4, up 3.3%, the highest absolute price throughout the four markets on the established pharmaceutical-excipient demand.
Indian prices moved from USD 1,480/MT in Q1 to USD 1,529 by Q4, a 3.3% gain, as the generic-formulation demand kept building through the year.
Expert Market Research: Your Source for Real-Time Benzoic Acid Excipient Price Intelligence
We keep a continuous eye on the benzoic acid excipient prices wherever it's produced or consumed at scale, tracing causation through the toluene feedstock economics, the pharmaceutical-formulation demand, and the purification capacity utilization for the USP-NF specifications. Our analysts track both the technical and pharmaceutical grades separately, given how differently the two markets can behave even though they share the same base chemistry. Need pricing data, bespoke market analysis, or procurement advisory? Reach out to our team. We also flag any material shift in toluene market conditions as soon as it appears in the underlying data.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
It works as an antimicrobial preservative in oral liquid pharmaceutical formulations and as a processing aid in some solid-dose manufacturing. A food-grade variant, E210, serves the same preservative function in packaged foods and beverages.
In Q2 2026, it averaged USD 1,443/MT in China, USD 1,794/MT in the US, USD 1,869/MT in Germany, and USD 1,580/MT in India, still the priciest market thanks to the established pharmaceutical-excipient demand.
The global average climbed from USD 1,569/MT in Q4 2025 to USD 1,595 in Q1 2026, then on to USD 1,621 in Q2, up 3.3% across the half.
The toluene feedstock costs firmed across every region, while the pharmaceutical-formulation demand held steady to strong across every market tracked.
We're expecting a global average somewhere in the USD 1,595-1,730/MT range, supported by the steady pharmaceutical and food-preservative demand.
Germany sits at the top on the established pharmaceutical-excipient demand. The US and India occupy a firm middle. China prices lowest on its large domestic production base.
The toluene feedstock costs matter most, followed by the pharmaceutical-formulation demand and the purification capacity utilization for meeting the USP-NF specifications.
China holds the largest production base, while Germany, the US, and India host established producers serving their own regional pharmaceutical industries.
Monthly, though our analysts flag any material shift in feedstock or logistics conditions between scheduled updates. Need something more current? Our team is available directly.
The quarterly trends and forecasts help time formulation-linked purchasing around the toluene feedstock cycles. Tracking the generic-drug manufacturing activity can help buyers anticipate demand shifts before they show up in the spot prices. Building that habit into a quarterly procurement review tends to pay off more than reacting to price moves after they have already happened.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.